Related references
Note: Only part of the references are listed.Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Yunjin Lee et al.
CHEMICAL REVIEWS (2021)
Novel naphthylamide derivatives as dual-target antifungal inhibitors: Design, synthesis and biological evaluation
Yunfei An et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Drug resistance and tolerance in fungi
Judith Berman et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses
Nancy A. Chow et al.
MBIO (2020)
Humanization of yeast genes with multiple human orthologs reveals functional divergence between paralogs
Jon M. Laurent et al.
PLOS BIOLOGY (2020)
Elevated Vacuolar Uptake of Fluorescently Labeled Antifungal Drug Caspofungin Predicts Echinocandin Resistance in Pathogenic Yeast
Qais Z. Jaber et al.
ACS CENTRAL SCIENCE (2020)
Synergistic effect of ibuprofen with itraconazole and fluconazole against Cryptococcus neoformans
Leticia Fernandes da Rocha et al.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Identification of Drug Resistant Candida auris
Milena Kordalewska et al.
FRONTIERS IN MICROBIOLOGY (2019)
Antifungal activity, mode of action variability, and subcellular distribution of coumarin-based antifungal azoles
Rebecca Elias et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Fungal Symbionts Produce Prostaglandin E2 to Promote Their Intestinal Colonization
Tze Guan Tan et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
FK506 Resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 Involves Mutations in the Transmembrane Domains and Extracellular Loops
Koichi Tanabe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Candida auris: an Emerging Fungal Pathogen
Emily S. Spivak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia
Alexander Rosenberg et al.
NATURE COMMUNICATIONS (2018)
Low-Cost Tetraplex PCR for the Global Spreading Multi-Drug Resistant Fungus, Candida auris and Its Phylogenetic Relatives
Amir Arastehfar et al.
FRONTIERS IN MICROBIOLOGY (2018)
Sterol 14α-Demethylase Structure-Based Optimization of Drug Candidates for Human Infections with the Protozoan Trypanosomatidae
Laura Friggeri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The antifungal pipeline: a reality check
John R. Perfect
NATURE REVIEWS DRUG DISCOVERY (2017)
Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis
Liliana Scorzoni et al.
FRONTIERS IN MICROBIOLOGY (2017)
Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia
C. Rueda et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Real-Time Imaging of the Azole Class of Antifungal Drugs in Live Candida Cells
Raphael I. Benhamou et al.
ACS CHEMICAL BIOLOGY (2017)
From Saccharomyces cerevisiae to human: The important gene co-expression modules
Wei Liu et al.
BIOMEDICAL REPORTS (2017)
Antimicrobial Effects of Antipyretics
Petra Zimmermann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Targeting efflux pumps to overcome antifungal drug resistance
Ann R. Holmes et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance
Kelley R. Healey et al.
NATURE COMMUNICATIONS (2016)
Flurbiprofen-antioxidant mutual prodrugs as safer nonsteroidal anti-inflammatory drugs: synthesis, pharmacological investigation, and computational molecular modeling
Zaman Ashraf et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Potential Antifungal Targets against a Candida Biofilm Based on an Enzyme in the Arachidonic Acid Cascade-A Review
Xinning Liu et al.
FRONTIERS IN MICROBIOLOGY (2016)
Drug resistance in eukaryotic microorganisms
Alan H. Fairlamb et al.
NATURE MICROBIOLOGY (2016)
Emerging Threats in Antifungal-Resistant Fungal Pathogens
Dominique Sanglard
FRONTIERS IN MEDICINE (2016)
Ibuprofen Potentiates the In Vivo Antifungal Activity of Fluconazole against Candida albicans Murine Infection
Sofia Costa-de-Oliveira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
COX inhibitors: a patent review (2011-2014)
Sara Consalvi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Systematic humanization of yeast genes reveals conserved functions and genetic modularity
Aashiq H. Kachroo et al.
SCIENCE (2015)
Ibuprofen-Mediated Reversal of Fluconazole Resistance in Clinical Isolates of Candida
Monika Sharma et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2015)
Arachidonic acid affects biofilm formation and PGE2 level in Candida albicans and non-albicans species in presence of subinhibitory concentration of fluconazole and terbinafine
Nripendra Nath Mishra et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2014)
Potent drugs that attenuate anti-Candida albicans activity of fluconazole and their possible mechanisms of action
Makoto Urai et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2014)
Candida albicans pathogenicity mechanisms
Francois L. Mayer et al.
VIRULENCE (2013)
Hidden Killers: Human Fungal Infections
Gordon D. Brown et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Design, Synthesis and Hydrolytic Behavior of Mutual Prodrugs of NSAIDs with Gabapentin Using Glycol Spacers
Monther Faisal Mahdi et al.
PHARMACEUTICALS (2012)
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
Annette C. Reboli et al.
BMC INFECTIOUS DISEASES (2011)
Antifungal activity of some cyclooxygenase inhibitors on Candida albicans: PGE2-dependent mechanism
Andreza Urba de Quadros et al.
FOLIA MICROBIOLOGICA (2011)
Current perspectives on echinocandin class drugs
David S. Perlin
FUTURE MICROBIOLOGY (2011)
A Clinical Isolate of Candida albicans with Mutations in ERG11 (Encoding Sterol 14α-Demethylase) and ERG5 (Encoding C22 Desaturase) Is Cross Resistant to Azoles and Amphotericin B
Claire M. Martel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Yeast Models of Human Mitochondrial Diseases
Antoni Barrientos
IUBMB LIFE (2010)
PKC Signaling Regulates Drug Resistance of the Fungal Pathogen Candida albicans via Circuitry Comprised of Mkc1, Calcineurin, and Hsp90
Shantelle L. LaFayette et al.
PLOS PATHOGENS (2010)
Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes
Elisabete Ricardo et al.
FEMS YEAST RESEARCH (2009)
Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms
Priya Uppuluri et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Stress, drugs, and evolution: The role of cellular signaling in fungal drug resistance
Leah E. Cowen et al.
EUKARYOTIC CELL (2008)
Synthesis, characterization and pharmacological evaluation of amide prodrugs of ketorolac
Ashutosh Mishra et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
NSAIDs, risks, and gastroprotective strategies: Current status and future
David Y. Graham et al.
GASTROENTEROLOGY (2008)
Characterization of prostaglandin E2 production by Candida albicans
John R. Erb-Downward et al.
INFECTION AND IMMUNITY (2007)
Sterol 14 alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms
Galina I. Lepesheva et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2007)
Indolyl esters and amides related to indomethacin are selective COX-2 inhibitors
AS Kalgutkar et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry
C Pina-Vaz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Evolution of antifungal-drug resistance: Mechanisms and pathogen fitness
JB Anderson
NATURE REVIEWS MICROBIOLOGY (2005)
Combination treatment of invasive fungal infections
PK Mukherjee et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans
R Arai et al.
MYCOSES (2005)
Current approaches to prevent NSAID-induced gastropathy - COX selectivity and beyond
JC Becker et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans
MAS Alem et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Antifungal agents: mechanisms of action
FC Odds et al.
TRENDS IN MICROBIOLOGY (2003)
Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei
C Onyewu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
New trends in dual 5-LOX/COX inhibition
X de Leval et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Molecular basis of resistance to azole antifungals
A Lupetti et al.
TRENDS IN MOLECULAR MEDICINE (2002)
Virulence factors of Candida albicans
RA Calderone et al.
TRENDS IN MICROBIOLOGY (2001)
Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins
MC Noverr et al.
INFECTION AND IMMUNITY (2001)
Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species
C Pina-Vaz et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2000)
Share Paper
